Case Series

Recurrent Urolithiasis Revealing Primary Hyperparathyroidism in a Nephrology Department

Table 1

Clinical features of our study population.

PatientsAge (years)/genderMedical historyHerbal infusionBMI/Weight (kg)Delay of diagnosis (years)Kidney stone’s locationSpontaneous emission of stonesUrological interventionKidney stone analysis

1 (WR)39/MHP-UIYes29.93/928BilateralECL-PCNLOx-Ca
Ox: 73%, Ca 20%

2 (BA)48/MHP26.2/7717UnilateralECL-surgeryOx-Ca
Ca: 60%, Ox: 22%
Infectious component

3 (DH)47/FHP26.47/766BilateralYesNoOx-Ph-Ca
Ca: 70%, Ph: 20%, Ox: 8%

4 (HR)38/FNo2BilateralYesOx-Ph-Ca
Ca: 75%, Ph: 20%, Ox: ..%

5 (NL)48/FHP diabetes32.23/751BilateralECL-PCNL surgeryPh-Ca
Ca: 50%, Ph: 38%

6 (GK)45/FHP-UIYes29.26/715BilateralECL-surgeryPh: 70%
Infectious component

7 (BAS)27/HNo-/935BilateralECLND

8 (NH)44/HNo-/872UnilateralYesNoCa-Ph
Ca: 85%, Ph: 15%

9 (DS)54/FNoYes-/75BilateralSurgeryPh-Ox-Ca
Ph: 70%, Ox: 17%,
Ca: 10%
Infectious component

10 (HI)34/FUI E. coliNo52/14110BilateralYesSurgery neprectomyND

ECL: extra corporeal lithotripsy, PCNL: percutaneous nephrolithotomy, and ND: none done.